|
|
|
|
InCode BioPharmaceutics, Inc
Appoints New President and CEO 11/20/2008 6:58:58 AM More...InCode BioPharmaceutics, Inc. Announces Key Safety Data for rC3-1: A New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 7/28/2008 6:31:40 AM More... InCode...
|
|
|
Significance of hemolysis on extracorporeal life support after cardiac surgery in children
Gbadegesin R et al.- Elevated levels of circulating plasma free hemoglobin (FHb) has been linked to the development of hemoglobinuria nephropathy. Compared with the no-CRRT group, the CRRT group had a higher mortality rate during...
|
|
|
Researchers to Present Additional Data on Soliris (eculizumab) for the Treatment of PNH at the ASH Annual Meet
/PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc.today announced that the American Society of Hematology (ASH) has published additional data relating to Soliris(R) (eculizumab) as a treatment for patients with paroxysmal nocturnal ...
|
|
|
David W. Keiser to Retire as President of Alexion
/PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc.announced today that David W. Keiser, the Company's Chief Operating Officer since 1992 and President since 2002, will retire by the end of 2008. Keiser, a co-founder of Alexion,...
|
|
|
Researchers to Present Additional Data on Soliris(R) (eculizumab) for the Treatment of PNH at the ASH Annual M
Initial Physician Experience with Eculizumab in Patients with Other Rare Complement-Mediated Diseases also to be Presented CHESHIRE, Conn., Nov.10 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. today announced that the American...
|
|
|
Researchers to Present Additional Data on Soliris(R) (eculizumab) for the Treatment of PNH at the ASH Annual M
Initial Physician Experience with Eculizumab in Patients with Other Rare Complement-Mediated Diseases also to be Presented CHESHIRE, Conn., Nov.10 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. today announced that the American...
|
|
|
Lifesaving drug based on OMRF research wins major industry honor
OKLAHOMA CITY A lifesaving drug based on work done at the Oklahoma Medical Research Foundation recently was honored with a major pharmaceutical industry award, officials said.The 2008 Prix Galien USA Award for Best Biotechnology Agent was...
|
|
|
Alexion Pharmaceuticals Chooses Blue Mountain Regulatory Asset Manager for Best-in-class Calibration Managemen
/PRNewswire/ -- Blue Mountain Quality Resources, Inc.announced today that Alexion Pharmaceuticals has chosen Blue Mountain Regulatory Asset Manager(R) to satisfy their immediate and long-term calibration management needs as part of their...
|
|
|
Alexion Pharmaceuticals Chooses Blue Mountain Regulatory Asset Manager(R) for Best-in-class Calibration Manage
STATE COLLEGE, Pa., Oct.28 /PRNewswire/ -- Blue Mountain Quality Resources, Inc. announced today that Alexion Pharmaceuticals has chosen Blue Mountain Regulatory Asset Manager(R) to satisfy their immediate and long-term calibration...
|
|
|
Alexion Pharmaceuticals Chooses Blue Mountain Regulatory Asset Manager(R) for Best-in-class Calibration Manage
STATE COLLEGE, Pa., Oct.28 /PRNewswire/ -- Blue Mountain Quality Resources, Inc. announced today that Alexion Pharmaceuticals has chosen Blue Mountain Regulatory Asset Manager(R) to satisfy their immediate and long-term calibration...
|
|
|
Alexion Pharmaceuticals Chooses Blue Mountain Regulatory Asset Manager(R) for Best-in-class Calibration Manage
STATE COLLEGE, Pa., Oct.28 /PRNewswire/ -- Blue Mountain Quality Resources, Inc. announced today that Alexion Pharmaceuticals has chosen Blue Mountain Regulatory Asset Manager(R) to satisfy their immediate and long-term calibration...
|
|
|
Alexion Pharmaceuticals Chooses Blue Mountain Regulatory Asset Manager(R) for Best-in-class Calibration Manage
STATE COLLEGE, Pa., Oct.28 /PRNewswire/ -- Blue Mountain Quality Resources, Inc. announced today that Alexion Pharmaceuticals has chosen Blue Mountain Regulatory Asset Manager(R) to satisfy their immediate and long-term calibration...
|
|
|
Alexion Pharmaceuticals Chooses Blue Mountain Regulatory Asset Manager(R) for Best-in-class Calibration Manage
STATE COLLEGE, Pa., Oct.28 /PRNewswire/ -- Blue Mountain Quality Resources, Inc. announced today that Alexion Pharmaceuticals has chosen Blue Mountain Regulatory Asset Manager(R) to satisfy their immediate and long-term calibration...
|
|
|
Alexion Pharmaceuticals Chooses Blue Mountain Regulatory Asset Manager(R) for Best-in-class Calibration Manage
STATE COLLEGE, Pa., Oct.28 /PRNewswire/ -- Blue Mountain Quality Resources, Inc. announced today that Alexion Pharmaceuticals has chosen Blue Mountain Regulatory Asset Manager(R) to satisfy their immediate and long-term calibration...
|
|
|
Alexion Pharmaceuticals Chooses Blue Mountain Regulatory Asset Manager(R) for Best-in-class Calibration Manage
STATE COLLEGE, Pa., Oct.28 /PRNewswire/ -- Blue Mountain Quality Resources, Inc. announced today that Alexion Pharmaceuticals has chosen Blue Mountain Regulatory Asset Manager(R) to satisfy their immediate and long-term calibration...
|
|
|
Alexion Pharmaceuticals Chooses Blue Mountain Regulatory Asset Manager(R) for Best-in-class Calibration Manage
STATE COLLEGE, Pa., Oct.28 /PRNewswire/ -- Blue Mountain Quality Resources, Inc. announced today that Alexion Pharmaceuticals has chosen Blue Mountain Regulatory Asset Manager(R) to satisfy their immediate and long-term calibration...
|
|
|
Alexion Pharmaceuticals Chooses Blue Mountain Regulatory Asset Manager(R) for Best-in-class Calibration Manage
STATE COLLEGE, Pa., Oct.28 /PRNewswire/ -- Blue Mountain Quality Resources, Inc. announced today that Alexion Pharmaceuticals has chosen Blue Mountain Regulatory Asset Manager(R) to satisfy their immediate and long-term calibration...
|
|
|
Alexion Pharmaceuticals Chooses Blue Mountain Regulatory Asset Manager(R) for Best-in-class Calibration Manage
STATE COLLEGE, Pa., Oct.28 /PRNewswire/ -- Blue Mountain Quality Resources, Inc. announced today that Alexion Pharmaceuticals has chosen Blue Mountain Regulatory Asset Manager to satisfy their immediate and long-term calibration...
|
|
|
Alexion Pharmaceuticals Chooses Blue Mountain Regulatory Asset Manager(R) for Best-in-class Calibration Manage
STATE COLLEGE, Pa., Oct.28 /PRNewswire/ -- Blue Mountain Quality Resources, Inc. announced today that Alexion Pharmaceuticals has chosen Blue Mountain Regulatory Asset Manager(R) to satisfy their immediate and long-term calibration...
|
|
|
Alexion Pharmaceuticals Chooses Blue Mountain Regulatory Asset Manager(R) for Best-in-class Calibration Manage
STATE COLLEGE, Pa., Oct.28 /PRNewswire/ -- Blue Mountain Quality Resources, Inc. announced today that Alexion Pharmaceuticals has chosen Blue Mountain Regulatory Asset Manager(R) to satisfy their immediate and long-term calibration...
|
|
|
Alexion Pharmaceuticals Chooses Blue Mountain Regulatory Asset Manager(R) for Best-in-class Calibration Manage
STATE COLLEGE, Pa., Oct.28 /PRNewswire/ -- Blue Mountain Quality Resources, Inc. announced today that Alexion Pharmaceuticals has chosen Blue Mountain Regulatory Asset Manager(R) to satisfy their immediate and long-term calibration...
|
|
|
Alexion Pharmaceuticals Chooses Blue Mountain Regulatory Asset Manager(R) for Best-in-class Calibration Manage
STATE COLLEGE, Pa., Oct.28 /PRNewswire/ -- Blue Mountain Quality Resources, Inc. announced today that Alexion Pharmaceuticals has chosen Blue Mountain Regulatory Asset Manager(R) to satisfy their immediate and long-term calibration...
|
|
|
Alexion Pharmaceuticals Chooses Blue Mountain Regulatory Asset Manager(R) for Best-in-class Calibration Manage
STATE COLLEGE, Pa., Oct.28 /PRNewswire/ -- Blue Mountain Quality Resources, Inc. announced today that Alexion Pharmaceuticals has chosen Blue Mountain Regulatory Asset Manager(R) to satisfy their immediate and long-term calibration...
|
|
|
Biotech Firm's Sales Explode On Drug To Treat Rare Blood Disorder
Developing new drugs is expensive.Just ask Alexion Pharmaceuticals.The Cheshire, Conn., drug discovery company has spent a cumulative $729 million over 15 years of research, working mostly on a drug to treat a rare and potentially fatal...
|
